Pharma/Biopharma
Systematic approach could help bring drug discovery ‘back to nature’
New method is an effective measure of a drug’s safety over time
PNNL scientist part of Pacific Northwest team that has solved 1,000 protein structures
The vaccine adds three more targets to a human vaccine candidate that showed promise
More accurate protein insights help researchers and pharmaceutical companies drive scientific breakthroughs
Researchers have discovered a way to structurally modify vancomycin to make an already-powerful version of the antibiotic even more potent
Small, randomized clinical trial reported measurable, but transient, benefits after single dose of suramin, highlighting novel causative theory and need for more, larger and longer trials
Penn researchers find blocking the activity of the ANGPTL3 protein strongly lowers triglycerides and cholesterol in pilot clinical trial
Scientists at Kyoto University have used a reengineered spider venom peptide to deliver biomacromolecules into a cell
Researchers are analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr Virus, or EBV
The findings, published online May 18 in the journal Cell, could lead to the first broadly effective ebolavirus therapies and vaccines
